The role of AHSNs in bringing together industry and NHS to stimulate economic growth -
Managing Director
East Midlands AHSN ( Academic Health Science Network)
Supporting innovation in the NHS -
Director of Innovation, Research and Life Sciences Group
NHS England
Refreshment Break -
Med-Tech Innovation Conference - Nicola Blackwood, Parliamentary Under-Secretary for Health and Social Care, Department of Health & Social Care -
Med-Tech Innovation Conference - John Wilkinson, OBE, Director of Devices, MHRA -
Innovation exchange and SBRI healthcare -
Getting your innovations into the NHS is known to be challenging – the Academic Health Science Networks (the NHS’s innovation agencies) have been the key points of assistance for the past 5 years. They have recently been commissioned by the Office of Life Science to create Innovation Exchanges where all of the 15 geographically based innovation agencies have a structured process of identification, assessment and support for validation and adoption – all designed to accelerate the route to adoption and transforming care for patients.

SBRI Healthcare is one of the support offered in the Innovation Exchange – it provides funds and targeted support for early stage companies and has a portfolio of over 150 companies developing solutions for healthcare needs.

In this session, Karen Livingstone, National Director of the Innovation Exchange and SBRI Healthcare will outline how you can register with your innovation exchange, secure the assistance of the AHSNs and potentially secure funding and resources through SBRI healthcare.  

National Director of the Innovation Exchange and SBRI Healthcare
NHS England
Refreshment Break -
3D printing and bioprinting and its relevance to the medical devices sector -

This presentation will give an overview of the growth of the use of 3D printing in the manufacture of medical devices, and the potential for bioprinting in the generation of combination products.

3D printing now has a 20 year track record of use in the manufacture of medical devices, and the presentation will review how applications have grown through application in teeth aligners, surgical guides, hearing aids and orthotics and prosthetics, and how the understanding and regulation of these products has matured over that time, and the outlook for future applications.

Bioprinting technologies are now emerging, and share much basic technology with 3D printing, and so working from the understanding gained from 3D printing’s history the presentation will explore how bioprinting could be used to enhance medical devices, generating combination products with enhanced functionality.

Professor of Manufacturing Engineering
Newcastle University
Growing and scaling the best UK MedTech businesses -
Interim Director Ageing Society, Health & Nutrition
Innovate UK
A national market access approach to accelerated adoption of technologies in the NHS -

Four years ago, Device Access was granted a commercial licence from NHS Digital to access over 900+million pseudonymised patient health records. This data allows them to examine diagnosis, procedure and spend data, nationally and by each NHS Hospital in England, and in turn enables Device Access to see how their client’s technology could affect the current patient pathway, assist in building a value story with NICE and a solid business case for local and national NHS Hospital adoption.

Michael will explain why the NHS needs technology more than ever before, and how companies need to develop a market access strategy around removing adoption barriers by communicating the benefits to patients, providers of care, payers of care and being able to justify the sales price and maximising the availability of the technology to the right patients.

Device Access UK
MedTech needs to get serious about investing in digital health -
Non-Executive Director and Chair
Digital Health and Care Institute Management
Designing efficiency and effectiveness for patients and organisations -

The medical device industry brings many innovative and iterative products to the healthcare market every year. How do the changing needs and demands of clinicians, patients, managers and policy-makers influence product design and how has this changed over the years? From the early days of the modern industry to some of the driving principles that impact development and design today.

What changes can we anticipate in the near future?

Increasingly the device industry has diversified into service provision. How do these services incorporate the perspective of the patient and bring greater efficiency?

How is demand stimulated and who is the real customer? Is industry responding in the right way or is there still a long way to go?

The behaviours and incentives in different health systems need to be considered in product and service development. At the same time the market is increasingly globalised. Can such diversity be incorporated at an affordable cost? How does the industry generate the data to demonstrate value & benefit – how is this designed in to evidence programmes?

Senior Director of Health Economics and Government Affairs
Boston Scientific
Refreshment Break -
Disruptive innovation in healthcare - who will design and manufacture? -
Royal Academy of Engineering Visiting Professor in Innovation
Cranfield Univeristy
Accelerated access collaborative and rapid uptake: the opportunity for invitro diagnostics to demonstrate value -
Director of Healthcare Development and Strategic Services (HDSS)
Roche Diagnostics
Refreshment Break -
The healthcare imperative: Taking an ecosystem approach to leadership -

Healthcare organisations and systems globally are facing unique pressures, many of which are strategic in nature. This session will outline the imperative for healthcare leaders to take an ecosystem approach in seeking to develop their strategy and in enabling new forms of value and innovation.  Whilst health organisations currently are overly focused on activities within their own organisational boundaries, this talk will suggest that new forms of value and new types of services cannot be delivered in isolation. Rather they require strategic partnerships and new business models that are enhanced when taking an ecosystem approach.

The presentation will focus on three areas; namely, what is an ecosystem, how can new forms of value be developed in ecosystems, and how is leadership exercised across ecosystem

Professor of Health Care Management
Warwick Business School, The University of Warwick
Med-Tech Innovation Conference - Dr James Carpenter, CEO, SurePulse Medical -
Med-Tech Innovation Conference - Jon Swinbourne, Operations Director, B13 Technologies -



Thanks to our supporters